This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tuppin, P.
Right arrow Articles by Grau, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tuppin, P.
Right arrow Articles by Grau, O.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, Nov 1997, 787-788, Vol 4, No. 6
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

High prevalence of antibodies to Mycoplasma penetrans in human immunodeficiency virus-seronegative and -seropositive populations in Brazzaville, Congo

P Tuppin, O Delamare, V Launay, M Gueguen, MC Samba, L Pambou, L Montagnier and O Grau
Unites d'Epidemiologie des Virus Oncogenes, Departement SIDA et Retrovirus, Institut Pasteur, Paris, France.

In industrialized countries, the prevalence of antibodies to Mycoplasma penetrans is higher among human immunodeficiency virus (HIV)- seropositive homosexuals than other HIV-seropositive and HIV- seronegative groups. In an African heterosexual population, we found a higher prevalence of M. penetrans antibodies in HIV-seronegative blood donors (15.5%) than in France (0.9%) or the United States (0.3%) and a prevalence of 13.4% in HIV-seropositive individuals. HIV-seropositive individuals with less than 5% CD4 cells had a higher prevalence of M. penetrans antibodies than individuals with 5% or more CD4 cells (25.0 versus 8.5%).